Correspondence 0001178913-24-001561 from TRINITY BIOTECH PLC (TRIB)
TRINITY BIOTECH PLC
Date: May 3, 2024 · CIK: 0000888721 · Accession: 0001178913-24-001561
AI Filing Summary & Sentiment
File numbers found in text: 333-279017
Show Raw Text
CORRESP
1
filename1.htm
TRINITY BIOTECH PLC
May 3, 2024
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, NE
Washington, D.C. 20549
Attention:
Lauren Hamill
Re: Trinity Biotech plc
Registration Statement on Form F-3
File No. 333-279017
To Ms. Hamill:
The undersigned, on behalf of Trinity Biotech plc (“Trinity”), issuer of the securities covered by the above-referenced Registration Statement, hereby respectfully requests that
the above-referenced Registration Statement be declared effective by the Securities and Exchange Commission at 9:00 am. Eastern Time on Tuesday, May 7, 2024, or as soon thereafter as possible.
Please contact Steven Glusband (212-238-8605, glusband@clm.com) or Mary Brown (212-238-8765, mbrown@clm.com) of Carter Ledyard & Milburn LLP with any questions you may have
concerning this request.
Very truly yours,
/s/ John Gillard
John Gillard
Chief Executive Officer